Endoscopy 2004; 36(7): 595-600
DOI: 10.1055/s-2004-814520
Original Article
© Georg Thieme Verlag Stuttgart · New York

Factors Influencing Clinical Applications of Endoscopic Balloon Dilation for Benign Esophageal Strictures

Y.-C.  Chiu1 , C.-C.  Hsu2 , K.-W.  Chiu1 , S.-K.  Chuah1 , C.-S.  Changchien1 , K.-L.  Wu1 , Y.-P.  Chou1
  • 1Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  • 2Division of Gastroenterology, Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan
Further Information

Publication History

Submitted 9 January 2003

Accepted after Revision 2 March 2004

Publication Date:
09 July 2004 (online)

Background and Study Aims: The purpose of this study was to investigate the safety and clinical effectiveness of a controlled radial expansion (CRE) balloon catheter in dilating benign esophageal strictures, and to assess factors influencing the effectiveness of this procedure.
Patients and Methods: From February 2000 to June 2002, 25 patients with documented benign esophageal strictures at our hospital were enrolled and treated with CRE balloon dilation. There were 17 men and eight women, with ages ranging from 30 to 82 years. The average age of the enrolled patients was 56.1 years. All of the strictures were dilated using CRE dilators under direct visualization, without fluoroscopic monitoring. The dilation diameters were planned in series up to 15 mm using a ”rule of three“. If dysphagia and esophageal strictures recurred during the clinical follow-up after completion of a series of dilations, additional dilation was carried out until symptomatic relief was achieved. Effective treatment was defined as the ability of patients with or without repeated dilations to maintain a solid or semisolid diet for more than 12 months. Depending on the effectiveness and duration of treatment, the patients were divided into three groups: group A, the successful group in which the initial series of dilations was effective without the need for any additional dilation for recurrent strictures or dysphagia; group B, the relapse group, in which the initial series of dilations was effective, but additional dilations were needed due to recurrent strictures or dysphagia; and group C, the group in which the initial series of dilations failed or consecutive dilations could not be carried out due to intolerance.
Results: The 25 patients received a total of 95 sessions of dilation (3.8 ± 1.2 sessions per patient). There were 11 patients in group A, 11 patients in group B, and three patients in group C. The median follow-up period was 16.5 months (range 12 - 32 months). The number of initial dilations required to achieve symptomatic relief showed a negative correlation with the pre-dilation diameter of the strictures (r = - 0.92, P < 0.01). Thinner strictures required more dilations before symptomatic relief was achieved. In addition, the stricture length in group B (5.4 ± 3.4 cm) was significantly longer than that in group A (2.6 ± 1.1 cm) (P = 0.009). The overall success rate was 88 % (22 of 25), including 100 % in the 21 patients with a stricture length of less than 8 cm and 25 % in the four patients with a stricture length more than 8 cm (P = 0.02).
Conclusions: CRE balloon dilation without fluoroscopy is an effective treatment for esophageal strictures less than 8 cm in length. Pre-dilation diameter and stricture length are factors that influence the numbers of dilations required and the need for additional dilations.

References

  • 1 Breslin N P, Thomson A BR, Bailey R J. et al . Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.  Gut. 2000;  46 93-97
  • 2 Kuo W H, Kalloo A N. Reflux strictures of the esophagus.  Gastrointest Endosc Clin N Am. 1998;  8 273-281
  • 3 McBride M A, Ergun G A. The endoscopic management of esophageal strictures.  Gastrointest Endosc Clin N Am. 1994;  4 595-621
  • 4 Goldstein J A, Barkin J S. Comparison of the diameter consistency and dilating force of the controlled radial expansion balloon catheter to the conventional balloon dilators.  Am J Gastroenterol. 2000;  95 3423-3427
  • 5 Tulman A B, Boyce H W. Complications of esophageal dilation and guidelines for their prevention.  Gastrointest Endosc. 1981;  27 229-234
  • 6 ASGE guideline. Esophageal dilation.  Gastrointest Endosc. 1998;  48 702-704
  • 7 Langdon D F. The rule of three in esophageal dilation.  Gastrointest Endosc. 1997;  45 111
  • 8 London R S, Trotman B W, Dimarino A J. et al . Dilatation of severe esophageal strictures by an inflatable balloon catheter.  Gastroenterol. 1981;  80 173-175
  • 9 Miller L S, Jackson W, McCray W. et al . Benign nonpeptic esophageal strictures.  Gastrointest Endosc Clin N Am. 1998;  8 329-347
  • 10 Ikeya T, Ohwada S, Ogawa T. et al . Endoscopic balloon dilation for benign esophageal anastomotic stricture: factors influencing its effectiveness.  Hepatogastroenterology. 1999;  46 959-966
  • 11 Honkoop P, Siersema P D, Tilanus H W. et al . Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management.  J Thorac Cardiovasc Surg. 1996;  111 1141-1148
  • 12 Cox J G, Winter R K, Maslin S C. et al . Balloon or bougie for dilatation of benign esophageal stricture?.  Dig Dis Sci. 1994;  39 776-781
  • 13 Whitworth P W, Richardson R L, Larson G M. Balloon dilatation of anastomotic strictures.  Arch Surg. 1988;  123 759-762
  • 14 Buess G, Thon J, Eitenmuller J. et al . The endoscopic multiple-diameter bougie: clinical results are after one year of application.  Endoscopy. 1983;  15 337-341
  • 15 Tucker L E. Esophageal stricture: result of dilation of 300 patients.  Mo Med. 1992;  89 668-670
  • 16 Parkman H P, Ogorek C P, Harris A D. et al . Nonoperative management of esophageal strictures following esophagomyotomy for achalasia.  Dig Dis Sci. 1994;  39 2102-2108
  • 17 Hernandez L V, Jacobson J W, Harris M S, Hernandez L J. Comparison among the perforation rates of Maloney, balloon, and Savary dilation of esophageal strictures.  Gastrointest Endosc. 2000;  51 460-462
  • 18 Botoman V A, Surawics C M. Bacteremia with gastrointestinal endoscopic procedures.  Gastrointest Endosc. 1986;  32 342-346
  • 19 Stephenson P M, Dorrington L, Harris O D. et al . Bacteraemia following oesophageal dilatation and oesophago-gastroscopy.  Aust NZ J Med. 1977;  7 32-35
  • 20 American Society for Gastrointestinal   Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy.  Gastrointest Endosc. 1995;  42 630-635
  • 21 Bancewicz J. A hazard of the Eder-Puestow system for oesophageal dilatation.  Br J Surg. 1979;  66 66
  • 22 Lanza F L, Graham D Y. Bougienage is effective therapy for most benign esophageal strictures.  JAMA. 1978;  240 844-847
  • 23 Mandelstam P, Surgawa C, Silvis S E. et al . Complications associated with esophagogastroduodenoscopy and with esophageal dilation.  Gastrointest Endosc. 1976;  23 16-19

C.-C. Hsu, M. D.

Division of Gastroenterology, Department of Internal Medicine · E-Da Hospital/I-Shou University

1, E-Da Road · Jiau-Shu Tsuen · Yan-Chau Shiang · Kaohsiung County, 824 · Taiwan ·

Fax: +886-7-6155352

Email: aladarhsu@yahoo.com.tw

    >